CLINICAL_TRIALS
trial_result
· 2018-06-29
Clinical Trial Update: Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus [Phase 3]
Summary
A Phase 3 clinical trial comparing epratuzumab to placebo in moderate to severe systemic lupus erythematosus has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UCB Pharma | Conditions: Systemic Lupus Erythematosus | Phase 3 | Status: COMPLETED | Results posted: 2018-06-29